Section 13 · Monograph

Enoxaparin

Reviewed Nov 2026FDA label
LovenoxLow-molecular-weight heparin
Forms
SC syringe: 30, 40, 60, 80, 100, 120, 150mg
Dose
VTE prophylaxis: 40mg SC once daily (30mg once daily if CrCl under 30mL/min); neuro-ICU start once hemorrhage is stable per guidelines
MOA
Potentiates antithrombin; inhibits factor Xa more than IIa

Black Box Warning

  • Epidural or spinal hematomas may occur in patients receiving enoxaparin with neuraxial anesthesia or spinal puncture, potentially causing long-term or permanent paralysis; risk is increased by indwelling catheters, concomitant NSAIDs, platelet inhibitors or other anticoagulants, traumatic or repeated puncture, and history of spinal deformity or surgery

Indications

  • Prophylaxis of deep vein thrombosis after abdominal, hip or knee surgery and in medical patients with restricted mobilityFDA-labeled
  • Treatment of acute DVT with or without pulmonary embolism; unstable angina and NSTEMI; STEMIFDA-labeled

Mechanism of Action

  • Low-molecular-weight heparin that potentiates antithrombin, preferentially inhibiting factor Xa over thrombin

Full Dosing

Adult / usual

  • Neurocritical care: start once hemorrhage (ICH, SAH, traumatic) is stable on repeat imaging, typically 24-72 hours, per guidelines

Renal

  • VTE prophylaxis: 40mg SC once daily (30mg SC once daily if CrCl below 30mL/min); some trauma/orthopedic protocols use 30mg twice daily
  • Hold before and after neuraxial procedures according to label timing; consider anti-Xa monitoring in obesity, pregnancy and renal impairment

Contraindications

  • Active major bleeding
  • History of immune-mediated heparin-induced thrombocytopenia (within the past 100 days or with circulating antibodies)
  • Hypersensitivity to enoxaparin, heparin or pork products

Drug Interactions

  • Anticoagulants, antiplatelets, NSAIDs, SSRIs and thrombolytics increase bleeding risk
  • Drugs that raise potassium add to heparin-induced hyperkalemia

Adverse Effects

  • Bleeding including intracranial and spinal hematoma
  • Heparin-induced thrombocytopenia (less than unfractionated heparin)
  • Injection-site hematoma
  • Elevated transaminases, hyperkalemia

Monitoring Parameters

  • Platelet count and hemoglobin
  • Serum creatinine and CrCl
  • Neurologic checks for spinal hematoma after neuraxial procedures; anti-Xa when indicated

Pregnancy & Lactation

  • Preferred anticoagulant in pregnancy (does not cross the placenta); use preservative-free forms when possible
  • Minimal oral absorption; compatible with breastfeeding

References

  1. LOVENOX (enoxaparin) Prescribing Information — DailyMed (NIH) search